Jubilant Pharmova has a diversified & unique business model with new growth drivers. 30% upside

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Oct 7, 2024.

Tags:
Previous Thread Next Thread
Loading...
  1. Vidhi Khanna

    Vidhi Khanna Well-Known Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    1,004
    Likes Received:
    55
    Jubilant Pharmova has a diversified & unique business model with new growth drivers & multiple triggers. It has growth visibility & revenue potential of $350 Mn. Co is embarking on a new earnings cycle. PAT has potential to grow 4x. TP ₹1450 (30%)

    Download research report

    [​IMG]
     
    Vidhi Khanna, Oct 7, 2024
    #1
Previous Thread Next Thread
Loading...
Loading...
Similar Threads
  1. Vidhi Khanna

    Buy Jubilant Pharmova for Target Price of ₹1385 (+46%)

    Vidhi Khanna, May 19, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    391
    Vidhi Khanna
    May 19, 2025
  2. Vidhi Khanna

    Jubilant is a conviction pick. TP ₹1420 (48%)

    Vidhi Khanna, Apr 4, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    378
    Vidhi Khanna
    Apr 4, 2025
  3. Vidhi Khanna

    Jubilant Foodworks is a hot pick with 41% upside

    Vidhi Khanna, Oct 9, 2022, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    741
    Vidhi Khanna
    Oct 9, 2022
  4. vineet

    Jubilant life sciences

    vineet, Jul 12, 2016, in forum: Stock Picks Of Wizards
    Replies:
    6
    Views:
    2,622
    w4wealth
    Aug 19, 2016
  5. Vidhi Khanna

    Jubilant Foodworks Ltd: The rise of the Quick Bite!!! - BUY

    Vidhi Khanna, Dec 23, 2015, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    2,112
    Vidhi Khanna
    Dec 23, 2015